DE60134576D1 - Arzneimittel zur linderung von darmerkrankungen - Google Patents

Arzneimittel zur linderung von darmerkrankungen

Info

Publication number
DE60134576D1
DE60134576D1 DE60134576T DE60134576T DE60134576D1 DE 60134576 D1 DE60134576 D1 DE 60134576D1 DE 60134576 T DE60134576 T DE 60134576T DE 60134576 T DE60134576 T DE 60134576T DE 60134576 D1 DE60134576 D1 DE 60134576D1
Authority
DE
Germany
Prior art keywords
intestinal
darmer
drugs
diseases
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60134576T
Other languages
English (en)
Inventor
Naoyuki Yamamoto
Osamu Masuda
Kyoko Kaneko
Nagisa Ikeda
Yuu Ishida
Daisuke Kusuda
Tadashi Shinoda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Soft Drinks Co Ltd
Original Assignee
Calpis Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Calpis Co Ltd filed Critical Calpis Co Ltd
Application granted granted Critical
Publication of DE60134576D1 publication Critical patent/DE60134576D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Dairy Products (AREA)
DE60134576T 2000-12-28 2001-12-25 Arzneimittel zur linderung von darmerkrankungen Expired - Lifetime DE60134576D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000401035A JP2002193817A (ja) 2000-12-28 2000-12-28 整腸剤
PCT/JP2001/011347 WO2002053163A1 (fr) 2000-12-28 2001-12-25 Medicaments pour soulager les troubles intestinaux

Publications (1)

Publication Number Publication Date
DE60134576D1 true DE60134576D1 (de) 2008-08-07

Family

ID=18865525

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60134576T Expired - Lifetime DE60134576D1 (de) 2000-12-28 2001-12-25 Arzneimittel zur linderung von darmerkrankungen

Country Status (11)

Country Link
US (1) US7029670B2 (de)
EP (1) EP1354592B1 (de)
JP (1) JP2002193817A (de)
KR (1) KR100845238B1 (de)
CN (1) CN1269489C (de)
AT (1) ATE399015T1 (de)
BR (1) BR0116636A (de)
DE (1) DE60134576D1 (de)
ES (1) ES2305132T3 (de)
TW (1) TWI285109B (de)
WO (1) WO2002053163A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003214038A1 (en) * 2002-04-03 2003-10-13 Chr. Hansen A/S Peptides with anti-hypertensive properties
US20040219237A1 (en) * 2002-06-25 2004-11-04 Kung-Ming Lu Process of using fermented Glycine max (L.) extract for enhancing natural killer cell activity and inhibitory activities to GABA and glutamate receptor binding
US7718171B2 (en) * 2003-04-07 2010-05-18 Chr. Hansen A/S Reducing heart rate in mammals using milk derived fermentation products produced using Lactobacillus helveticus
WO2006045347A1 (en) * 2004-10-22 2006-05-04 Medinova Ag Lactobacillus helveticus strain useful in the treatment or prevention of infections caused by urogenital pathogens
JP2008074768A (ja) * 2006-09-21 2008-04-03 Yumex Biotech Co Ltd 宿主特異的プロバイオティクス製品
KR100808910B1 (ko) 2006-10-19 2008-03-03 주식회사 씨티씨바이오 항균 및 항바이러스 효과를 가진 신규한 유산균 및 이를포함하는 조성물
US9492487B2 (en) * 2010-02-01 2016-11-15 Matthew Ryan Garner Microbial product containing multiple microorganisms
KR101235561B1 (ko) * 2010-12-09 2013-03-21 주식회사 제일바이오 항바이러스 및 항균 활성을 갖는 락토바실러스 플란타룸 ｃｌｐ-1 균주 및 이를 포함하는 생균제
CN102948476A (zh) * 2012-11-19 2013-03-06 陕西科技大学 一种基于瑞士乳杆菌发酵的含ace抑制肽的羊乳饮料的制备方法
CN104095219A (zh) * 2013-04-03 2014-10-15 赵景芳 一种益生菌整肠药剂的制备方法
WO2022196488A1 (ja) * 2021-03-15 2022-09-22 森永乳業株式会社 Ｑｏｌを改善するための組成物

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5528M (de) * 1965-10-01 1967-11-13
US3846560A (en) 1971-07-22 1974-11-05 Quaker Oats Co Process of making a base for protein beverages
US3876806A (en) 1971-10-14 1975-04-08 Quaker Oats Co Process for the preparation of acid soluble polypeptides and carbonated beverages containing same
US4107334A (en) 1976-10-13 1978-08-15 Pfizer Inc. Modified protein
CH636248A5 (fr) 1979-03-09 1983-05-31 Nestle Sa Procede de preparation d'un hydrolysat de proteines purifie.
JPS60262561A (ja) 1984-06-08 1985-12-25 House Food Ind Co Ltd 大豆蛋白質水溶液の処理方法
US4585757A (en) * 1984-07-27 1986-04-29 Texas Tech University Health Sciences Center Hypotensive active peptides
US4687840A (en) * 1986-02-11 1987-08-18 Texas Tech University Health Sciences Center Hypotensive active peptides
US4980164A (en) * 1986-10-02 1990-12-25 Bio Techniques Laboratories, Inc. Strains of lactobacillus for enhancing feed conversion efficiency
DD300815A5 (de) * 1989-07-07 1992-08-06 Nestle Sa Proteinhydrolyse
JP2890746B2 (ja) 1989-08-24 1999-05-17 日本油脂株式会社 高安定性腸内有用細菌を含有する食品
NL9000422A (nl) * 1990-02-21 1991-09-16 Nl Zuivelonderzoek Inst Werkwijze voor de bereiding van een gefermenteerd melkprodukt.
EP0445606B1 (de) * 1990-02-27 1997-01-22 The Agency of Industrial Science and Technology Oligopeptide, sie enthaltende pharmazeutische und Futterzusammensetzung und Benützung von Oligopeptiden
DE69127020T2 (de) * 1990-05-18 1998-01-29 Iwase Cosfa Co Ltd Milchproteinhydrolysate und Zusammensetzungen zur Verwendung als Haar- und Hautbehandlungsmittel
JP2571734B2 (ja) * 1991-08-23 1997-01-16 株式会社ヤクルト本社 乳酸菌飲料
US5486461A (en) * 1991-11-08 1996-01-23 Novo Nordisk A/S Casein hydrolyzate and method for production of such casein hydrolyzate
JPH05236872A (ja) 1992-02-27 1993-09-17 Takanashi Nyugyo Kk 乳酸菌含有食品
FI94088C (fi) 1992-03-13 1995-07-25 Valio Oy Menetelmä fenyylialaniinin poistamiseksi proteiinipitoisista koostumuksista
JPH05292947A (ja) 1992-04-17 1993-11-09 Sanei Touka Kk ラクトバチルス・アシドフィルスｐｎ−ｒｉ−２−４、それを用いた乳酸菌製剤及びその製造方法
US5418218A (en) * 1992-07-10 1995-05-23 The University Of Maryland At Baltimore Histidyl-proline diketopiperazine (cyclo his-pro) a cns-active pharmacologic agent
JPH0787800A (ja) * 1993-09-13 1995-03-31 Meidensha Corp インバータの自動トルクブースト制御およびすべり補償制御装置
JP3436581B2 (ja) 1994-03-18 2003-08-11 雪印乳業株式会社 乳糖分解酵素活性の高い菌体の製造法
US5656268A (en) * 1995-04-21 1997-08-12 Sorodsky; Michael Biological product
US5618689A (en) 1995-05-25 1997-04-08 Nestec S.A. Enhanced procedures for preparing food hydrolysates
JPH092959A (ja) * 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
JP3746556B2 (ja) * 1996-02-09 2006-02-15 カルピス株式会社 プラスミド及びプラスミドベクター
JPH10146157A (ja) 1996-11-18 1998-06-02 Kao Corp 食用微生物含有フィルム状食品
DK0946106T3 (da) * 1996-12-23 2002-09-16 Dsm Nv Fremgangsmåde til fremstilling af et proteinhydrolysat
JP3158090B2 (ja) 1998-02-26 2001-04-23 雪印乳業株式会社 新規乳酸菌株
US6221423B1 (en) * 1998-04-13 2001-04-24 Protein Technologies Int'l Inc. Short-chained peptide material
JP3291250B2 (ja) * 1998-07-15 2002-06-10 農畜産業振興事業団 ホエー飲料とその製造法
JP2000197469A (ja) * 1999-01-08 2000-07-18 New Food Creation Gijutsu Kenkyu Kumiai 血清脂質改善効果を有する機能性飲食品
AU2001245537A1 (en) 2000-03-10 2001-09-24 Monsanto Company Anti-hypertensive peptides
WO2001068114A1 (en) 2000-03-10 2001-09-20 Monsanto Company Novel peptides with anti-hypertensive activity
US6908633B2 (en) * 2000-03-13 2005-06-21 Morinaga Milk Industry Co., Ltd. Protein hydrolyzates, process for producing the same and drinks and foods containing the protein hydrolyzates
US20030040475A1 (en) * 2001-01-16 2003-02-27 Yasuhiro Toba Agents for improving lipid metabolism and reducing high blood pressure
US6815426B2 (en) * 2001-02-16 2004-11-09 E. I. Du Pont De Nemours And Company Angiogenesis-inhibitory tripeptides, compositions and their methods of use
WO2002071854A1 (en) * 2001-03-09 2002-09-19 Unilever N.V. Fermented milk product
US6589574B2 (en) * 2001-03-19 2003-07-08 Council Of Scientific & Industrial Research Process for preparation of protein-hydrolysate from milk protein

Also Published As

Publication number Publication date
ES2305132T3 (es) 2008-11-01
EP1354592B1 (de) 2008-06-25
KR100845238B1 (ko) 2008-07-10
ATE399015T1 (de) 2008-07-15
BR0116636A (pt) 2003-12-23
EP1354592A1 (de) 2003-10-22
KR20030070591A (ko) 2003-08-30
EP1354592A4 (de) 2005-06-08
CN1269489C (zh) 2006-08-16
TWI285109B (en) 2007-08-11
US20040096434A1 (en) 2004-05-20
CN1492764A (zh) 2004-04-28
JP2002193817A (ja) 2002-07-10
US7029670B2 (en) 2006-04-18
WO2002053163A1 (fr) 2002-07-11

Similar Documents

Publication Publication Date Title
Zhang et al. Cerebral mast cells contribute to postoperative cognitive dysfunction by promoting blood brain barrier disruption
WO2008085484A3 (en) Treatment of inflammatory bowel disease with enteric coated formulations comprising 5-aminosalicylic acid or 4-aminosalicylic acid
DE60134576D1 (de) Arzneimittel zur linderung von darmerkrankungen
ATE432072T1 (de) Verwendung von adapalen zur behandlung dermatologischer erkrankungen
CA2157927A1 (en) Therapeutic uses of bactericidal/permeability increasing protein produc ts
ATE508738T1 (de) System zur beabstandeten abgabe von arzneimitteln
BRPI0412526A (pt) composto, uso de um composto, composição farmacêutica, formulação em aerossol farmacêutica, e, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica
WO2005034843A3 (en) Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
CY1105199T1 (el) Θepαπευτικες συνθεσεις για αντιμετωπιση της υπepεκκρισης βλεννας
DE60237363D1 (de) Verfahren zur behandlung von entzündlichen erkrankungen des verdauungstrakts mit topisch wirksamen kortikosteroiden
DK1151009T3 (da) Antimikrobielt/endotoksin-neutraliserende polypeptid
DK0617623T3 (da) Acetylsalicylsyreholdigt transdermalt indgivelsessystem til antithrombotisk behandling
MY145329A (en) Gastroresistant pharmaceutical dosage form comprising n-(2-(2-phthalimidoethoxy)-acetyl)-l-alanyl-d-glutamic acid (lk-423)
NO20051669L (no) Fremgangsmater og reagenser for behandling av sykdommer og forstyrrelser assosiert med okte nivaer av proinflammatoriske cytokiner
CY1106155T1 (el) Χρηση παραγωγων 3-βενζολοφαινυλοξικων οξεων για την αντιμετωπιση διαταραχων του αμφιβληστροειδους
AU2742892A (en) An anticoagulant substance obtained from urine
Ge et al. Differential metabolic and inflammatory responses to intermittent hypoxia in substrains of lean and obese C57BL/6 mice
PT981362E (pt) Metodos de melhoramento do funcionamento do tracto gastrointestinal superior
BR0310061A (pt) Métodos para o tratamento de doenças e condições respiratórias com um inibidor seletivo da inos e um inibidor da pde e suas composições
DE69334068D1 (de) Kontrolle der wundvernarbung mit calmodulin-inhibitoren oder protein-kinase-c-inhibitoren
NO20051159L (no) Preparater og fremgangsmater for behandling av sykdommer som viser feilsammensetting av aggregering av protein
Kurz et al. Activation of healing and reduction of pain by single‐use automated microcurrent electrical stimulation therapy in patients with hard‐to‐heal wounds
WO2004010934A3 (en) Methods for the use of neurotoxin in the treatment of urologic disorders
CO5261512A1 (es) Metodo y composiciones para el tratamiento de las enfermedades pulmonares
NO20021410L (no) Forebygging og behandling av blodkoagulasjons-relaterte sykdommer

Legal Events

Date Code Title Description
8364 No opposition during term of opposition